LONDON--(BUSINESS WIRE)--The global antimicrobial susceptibility testing market is expected to grow by USD 900.75 million as per Technavio. This marks a significant market slowdown compared to the 2019 growth estimates due to the impact of the COVID-19 pandemic in the first half of 2020. However, healthy growth is expected to continue throughout the forecast period, and the market is expected to grow at a CAGR of over 5%.
Request challenges and opportunities that influence COVID-19 pandemic - Request free sample pages of the antimicrobial susceptibility testing market
Read the 120-page report with TOC on "Antimicrobial Susceptibility Testing Market Analysis Report by Application (Clinical diagnostics, Drug discovery and development, and Others), Geography (North America, Europe, Asia, and ROW), and the Segment Forecasts, 2020-2024".
The market is driven by the increasing prevalence of infectious diseases. In addition, increasing government initiatives is anticipated to boost the growth of the antimicrobial susceptibility testing market.
Factors such as a rapidly growing population, lifestyle changes, urbanization, and climate change have increased the prevalence of infectious diseases. In 2017, about 134 per 100,000 people were diagnosed with tuberculosis globally and 90%-95% of tuberculosis deaths occurred in low and middle-income countries. Also, recent outbreaks such as Ebola, Zika, dengue, the Middle East Respiratory Syndrome (MERS), influenza, and Severe Acute Respiratory Syndrome (SARS) have further increased the concerns around global health. Such frequent outbreaks have necessitated the need for the identification of various disease-causing bacteria and viruses. Antimicrobial susceptibility testing is widely used in the diagnosis of such infectious diseases. Therefore, the increasing prevalence of infectious diseases is expected to drive the growth of the global antimicrobial susceptibility testing market.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Major Five Antimicrobial Susceptibility Testing Companies:
Accelerate Diagnostics Inc.
Accelerate Diagnostics Inc. operates its business through a unified business segment. The company offers Accelerate Pheno system, which is a fully automated testing device.
ALIFAX Srl operates its business through segments such as BACTERIOLOGY LINE, ESR LINE, COLLECTION DEVICES, and SAMPLE TRANSPORTATION. The company offers Rapid Antimicrobial Susceptibility Test. Its results facilitate effective treatment, leading to a reduction in the number of laboratory tests ordered, duration of days of hospitalization, and overall public health costs.
Becton, Dickinson and Co.
Becton, Dickinson and Co. operates its business through segments such as BD Medical, BD Life Sciences, and BD Interventional. The company offers various antimicrobial susceptibility testing for the medical industry.
bioMérieux SA operates its business through segments such as Clinical applications and Industrial applications. The company offers ETEST. It is offered as test strips and is considered reliable for determining the on-scale minimum inhibitory concentration (MIC) of antibiotics, antifungal agents, and anti-mycobacterial agents.
Bio-Rad Laboratories Inc.
Bio-Rad Laboratories Inc. operates its business through segments such as Life Science and Clinical Diagnostics. The company offers ADAGIO. It is offered as an AST system that generates rapid and accurate results, which complies with CLSI or EUCAST guidelines.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Antimicrobial Susceptibility Testing Market Application Outlook (Revenue, USD Million, 2020-2024)
- Clinical diagnostics
- Drug discovery and development
Antimicrobial Susceptibility Testing Market Regional Outlook (Revenue, USD Million, 2020-2024)
- North America
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
Related Reports on Healthcare Include:
Global Antimicrobial Therapeutics Market – Global antimicrobial therapeutics market by application (antiviral, antibacterial, antifungal, and antiparasitic) and geography (Asia, Europe, North America, and ROW).
Global Chronic Fatigue Syndrome Therapeutics Market – Global chronic fatigue syndrome therapeutics market by product (pain relievers and nonsteroidal anti-inflammatory drugs (NSAIDs), antidepressant and antipsychotic drugs, and antimicrobial and immunomodulatory drugs) and geography (Asia, Europe, North America, and ROW).
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.